How Inflammation Silently Damages Your Arteries (And How to Stop It)

Published: March 21, 2026  ·  Last updated: April 28, 2026

For most of the late 20th century, the heart-disease story was about cholesterol clogging arteries like grease in a pipe. The mechanism is more complicated than that. What actually drives a heart attack is a smoldering inflammatory process inside the artery wall — a process you cannot feel, do not see, and which the standard cholesterol panel only partially captures.

The medical term is residual inflammatory risk. It is the share of cardiovascular events that keep happening even after LDL is at goal. The way to detect it is a blood test most people have never had. The way to address it overlaps heavily with the lifestyle changes that benefit almost everything else.

Why arteries inflame in the first place

Atherosclerosis begins when LDL particles slip past the inner artery lining (the endothelium) and lodge in the wall. Once trapped, the particles get oxidized, and the immune system shows up to clean them up. Macrophages — a type of white blood cell — engulf the LDL, become foam cells, and release inflammatory signals that recruit more immune cells.

The plaque that forms over years is not pure cholesterol. It is cholesterol, foam cells, fibrous tissue, calcium, and an active immune-cell population that keeps the inflammation simmering. When that plaque becomes unstable and ruptures, the resulting clot is what causes a heart attack or stroke.

This is why every step of plaque formation, progression, and rupture is now understood as inflammation-driven. The cholesterol initiates the process; the immune response sustains and worsens it.

What hs-CRP tells you that LDL doesn't

C-reactive protein is a marker of systemic inflammation. The high-sensitivity version (hs-CRP) is calibrated to detect the low-grade chronic inflammation linked to cardiovascular disease. Elevated hs-CRP is independently associated with increased risk of heart attack and stroke — meaning it adds risk information beyond what cholesterol numbers alone provide.

The American Heart Association notes that hs-CRP can help identify people whose risk is not fully captured by their lipid panel. The test runs about $10–$30, fasting is usually not required, and a single value is most meaningful when paired with at least one repeat to confirm it is not reflecting a recent infection or injury.

Common reference ranges describe hs-CRP under 1 mg/L as low cardiovascular risk, 1–3 mg/L as average, and above 3 mg/L as high. Values above 10 mg/L typically reflect acute illness or injury rather than chronic inflammatory risk.

Lifestyle is the first-line anti-inflammatory

The fastest way to lower hs-CRP for most people is the set of changes that lower cardiovascular risk in general: weight loss when needed, regular aerobic activity, a Mediterranean-style eating pattern, adequate sleep, smoking cessation, and stress management. Each of these has been shown in trials to reduce systemic inflammation markers, including hs-CRP, on a timescale of weeks to months.

Specific dietary levers with the most consistent anti-inflammatory evidence: replacing refined carbohydrates with intact whole grains, increasing vegetables and fruit, swapping saturated fats for monounsaturated and omega-3 sources, and cutting back on ultra-processed foods. None of these are exotic. They are the same levers cardiology has been recommending for decades, recast in inflammation terms.

Cleveland Clinic and other major centers note that the degree of inflammation in your arteries can be a stronger predictor of events than cholesterol alone — which makes the lifestyle work both prevention and treatment.

When medication enters the picture

Statins lower LDL-C and also reduce hs-CRP — part of why they work as well as they do. For people with elevated hs-CRP whose LDL is already at goal, the picture is different. Recent trials suggest specific anti-inflammatory medications (low-dose colchicine is one example, FDA-approved in 2023 for cardiovascular event reduction in select patients with established atherosclerotic disease) can reduce events further by directly damping inflammation.

These are not first-line tools and not appropriate for everyone. But they are part of why measuring inflammation matters: if it is high and lifestyle interventions are not bringing it down, additional options exist that simply do not exist for someone whose risk is being inferred from cholesterol alone.

The bottom line: cholesterol still matters. Inflammation is the rest of the story. The two together explain cardiovascular risk better than either alone.

To your health,

Ageless CoachTM

Age Strong. Live Long.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.